「dpo」の検索結果

Debug Spring Boot issues systematically. Use when encountering bean errors like NoSuchBeanDefinitionException, circular dependency issues, application startup failures, JPA/Hibernate problems including LazyInitializationException and N+1 queries, security misconfigurations causing 403 Forbidden errors, property binding failures, CSRF token issues, or any Spring Boot application requiring diagnosis with Actuator endpoints and JVM debugging.

日本語の概要は準備中です。原文の説明を表示しています。

Genera endpoints REST con Kotlin + Spring Boot 3.4+ (Records, Virtual Threads, ProblemDetail)

日本語の概要は準備中です。原文の説明を表示しています。

Create Convex queries, mutations, and actions with proper validation, authentication, and error handling. Use when implementing new API endpoints.

日本語の概要は準備中です。原文の説明を表示しています。

Guide for building and refactoring a FastAPI + Prefect + PostgreSQL/pgvector analytics pipeline that extracts insights from chat data using LLM classification, embeddings, UMAP/HDBSCAN clustering, and narrative generation. Use this skill whenever working on this project's codebase — including adding features, refactoring, debugging, creating new endpoints, modifying pipeline stages, or reviewing architecture decisions. Also trigger when the user asks about project structure, stack decisions, async migration, or best practices for this specific system.

日本語の概要は準備中です。原文の説明を表示しています。

Azure Monitor Ingestion SDK for Java. Send custom logs to Azure Monitor via Data Collection Rules (DCR) and Data Collection Endpoints (DCE).

日本語の概要は準備中です。原文の説明を表示しています。

Provide comprehensive techniques for penetration testing AWS cloud enprojectnments. Covers IAM enumeration, privilege escalation, SSRF to metadata endpoint, S3 bucket exploitation, Lambda code extraction, and persistence techniques for red team operations.

日本語の概要は準備中です。原文の説明を表示しています。

Generate comprehensive, developer-friendly API documentation from code, including endpoints, parameters, examples, and best practices

日本語の概要は準備中です。原文の説明を表示しています。

Access the Firebase Emulator Suite (Firestore, Auth, Functions, Hub) via REST and Admin SDK without trial-and-error. Use this skill whenever you read/write/query/clear Firestore Emulator data, create test users or obtain ID tokens from the Auth Emulator, verify Functions triggers, seed/export emulator data, or hit unexpected 403/404 from an emulator endpoint. Consult it BEFORE curling any emulator port — it encodes the auth header and host-resolution rules that otherwise cause retries.

日本語の概要は準備中です。原文の説明を表示しています。

Design clean, scalable, and maintainable REST and GraphQL APIs following industry best practices. Use when designing public or internal APIs, planning endpoint structures, defining request/response contracts, establishing versioning strategies, implementing authentication patterns, designing data models, creating API documentation, ensuring consistent error handling, optimizing for performance, or establishing service contracts between microservices.

日本語の概要は準備中です。原文の説明を表示しています。

Implement comprehensive security patterns to protect applications against OWASP Top 10 vulnerabilities including XSS, CSRF, SQL injection, authentication bypass, and data exposure. Use when handling user data, implementing authentication and authorization, validating input, encrypting sensitive data, preventing injection attacks, securing API endpoints, managing sessions and tokens, implementing rate limiting, configuring security headers, or building security-critical features that require defense-in-depth protection.

日本語の概要は準備中です。原文の説明を表示しています。

Configure deployment settings for /land-and-deploy. Detects your deploy platform (Fly.io, Render, Vercel, Netlify, Heroku, GitHub Actions, custom), production URL, health check endpoints, and deploy status commands. Writes the configuration to CLAUDE.md so all future deploys are automatic. Use when: "setup deploy", "configure deployment", "set up land-and-deploy", "how do I deploy with gstack", "add deploy config".

日本語の概要は準備中です。原文の説明を表示しています。

Generate realistic, correctly-linked Frappe/ERPNext test records for any DocType using the `bench faker` CLI, then roll them back when done. Use when a test, demo, or local repro needs seed data and the site is missing it — e.g. "I need some Sales Orders", "seed data so I can test this API", "create test Employees in Chennai", or "populate the database to test this endpoint".

日本語の概要は準備中です。原文の説明を表示しています。

Design stable APIs and module boundaries — contract-first types, consistent errors, boundary validation, additive changes. Load when designing REST or GraphQL endpoints, public module interfaces, component props, or FE/BE contracts. Also triggers on "API design", "interface design", "design the API", "module boundary", "API contract", "define the interface". Complements feature-spec (product layer). Routes breaking retirement to api-deprecation-and-migration when it exists.

日本語の概要は準備中です。原文の説明を表示しています。

This skill ensures all code follows security best practices and identifies potential vulnerabilities. Use when implementing authentication or authorization, handling user input or file uploads, or creating new API endpoints.

日本語の概要は準備中です。原文の説明を表示しています。

Azure Monitor Ingestion SDK for Java. Send custom logs to Azure Monitor via Data Collection Rules (DCR) and Data Collection Endpoints (DCE).

日本語の概要は準備中です。原文の説明を表示しています。

Provide comprehensive techniques for penetration testing AWS cloud environments. Covers IAM enumeration, privilege escalation, SSRF to metadata endpoint, S3 bucket exploitation, Lambda code extraction, and persistence techniques for red team operations.

日本語の概要は準備中です。原文の説明を表示しています。

Generate comprehensive, developer-friendly API documentation from code, including endpoints, parameters, examples, and best practices

日本語の概要は準備中です。原文の説明を表示しています。

Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.

日本語の概要は準備中です。原文の説明を表示しています。

Maps between gene identifier systems (Ensembl, Entrez, HGNC symbol, UniProt, RefSeq, MANE) using AnnotationDbi, biomaRt, mygene, pyensembl, and Ensembl REST. Encodes Ensembl version stripping with GENCODE _PAR_Y preservation, the Ziemann 2016 Excel autocorrect debacle and Bruford 2020 HGNC renames (SEPT*->SEPTIN*, MARCH*->MARCHF*, MARC*->MTARC*, DEC1->DELEC1), OCT4/POU5F1 alias resolution, biomaRt archive endpoints for release pinning, the `filters` (plural) gotcha, MANE Select for clinical reporting, cross-species orthology via Ensembl Compara / OMA / OrthoDB, and tx2gene construction for tximport. Use when converting gene IDs across systems, handling renamed symbols, building tx2gene, pinning to a specific Ensembl release for reproducibility, or mapping cross-species orthologs.

日本語の概要は準備中です。原文の説明を表示しています。

Quality control for pooled CRISPR screens covering library representation, Gini index, log-skew, replicate Pearson and Spearman concordance, essentialome precision-recall AUC against CEGv2 (Hart 2017), Cas9 cut-toxicity diagnostics, copy-number amplicon detection (Aguirre 2016 / Munoz 2016), bottleneck propagation through plasmid pool, infection, selection, and endpoint stages, MOI verification, and DepMap-style screen-quality scoring. Use when assessing screen quality before hit calling, deciding whether to repeat or rescue a screen, diagnosing low-confidence hits, choosing between MAGeCK / BAGEL2 / Chronos based on quality grade, picking a normalization strategy from QC signatures, or evaluating whether an in-vivo screen retained adequate library complexity.

日本語の概要は準備中です。原文の説明を表示しています。

Query the Ensembl REST API for gene/transcript/protein lookup, sequence retrieval, comparative genomics (Compara), variant effect prediction (VEP), regulatory features, and cross-species ortholog/paralog calls. Use when pulling Ensembl-native data (Ensembl Gene IDs, version-pinned releases, archive endpoints for reproducibility), gene/transcript/exon structure with stable IDs, or VEP for variant annotation. Encodes the 15 req/sec rate limit, archive (e110.rest.ensembl.org) for reproducibility, Ensembl divisions (vertebrates / plants / fungi / metazoa / bacteria), and the symbol-vs-ID stability problem.

日本語の概要は準備中です。原文の説明を表示しています。

Bulk-query Ensembl BioMart (and other BioMart instances) for cross-database ID mapping, gene/transcript/exon coordinates, and ortholog tables. Use when batch-converting Ensembl IDs to other namespaces (HGNC, RefSeq, UniProt, Entrez), pulling gene coordinate tables for thousands of genes, building ortholog wide-tables across species, or replacing slow Ensembl REST loops with one-shot bulk export. Encodes BioMart's XML query format, R biomaRt vs Python pybiomart trade-off, mart-vs-dataset hierarchy, and the URL endpoint that's BioMart-specific (separate from rest.ensembl.org).

日本語の概要は準備中です。原文の説明を表示しています。

Performs time-to-event analysis for clinical trials including Cox proportional hazards regression with PH diagnostics, restricted mean survival time (RMST) under non-PH, competing risks via Fine-Gray vs cause-specific Cox, weighted log-rank and MaxCombo for non-proportional hazards, recurrent events (Andersen-Gill, PWP, WLW), and interval-censored data. Use when analyzing time-to-event endpoints (OS, PFS, DOR, TTR, TTNT) in oncology or other clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 80-125% bioequivalence; minimum clinically important difference (MCID) vs δ distinction. Use when justifying trial size in protocol or SAP per CONSORT 2025 item 7.

日本語の概要は準備中です。原文の説明を表示しています。